
|Articles|August 20, 2012
Considerations for the Development and Manufacturing of Biosimilars [Presentation]
Advertisement
This content is provided by Amgen.
Divided into 3 sections, this presentation provides insight into the complexities of developing and manufacturing biologics and discusses considerations for the development of biosimilars.
Please click the image below to view the presentation.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
CD19 CAR T-Cell Therapy Shows Promising Activity in Richter Transformation
2
2025 Hypertension Guideline Updates Presented at AHA Scientific Sessions
3
5 AI and Digital Health Advances Transforming Breast Cancer Care and Research
4
US Spending on High-Revenue Rare Disease Drugs in 2022
5














































